Curcuma Longa
Curcumin is the primary bioactive compound in turmeric (Curcuma longa). It has been extensively studied for its anti-inflammatory, antioxidant, and metabolic effects.
In a longevity context, curcumin is particularly relevant due to its ability to modulate chronic inflammation, a key driver of ageing and many chronic diseases.
Curcumin influences several biologicalpathways:
- Reduces inflammation by inhibiting NF-κB
- Acts as an antioxidant and increases endogenous antioxidant enzymes
- Modulates cytokines such as TNF-α and IL-6
These mechanisms underpin many of its observed health effects.
Curcumin has been shown to reduce markers of chronic inflammation.
RCTs show improvements in symptoms of osteoarthritis.
Curcumin improves glucose control and lipid markers in some populations.
Chronic inflammation is linked to cardiovascular disease, diabetes, and neurodegeneration.
Randomised controlled trial · Adults with knee osteoarthritis · 4 weeks
Curcumin was as effective as ibuprofen in reducing pain and improving function.
View study on PubMed →Randomised controlled trial - 60 patients - 6 weeks
This study provided clinical evidence that curcumin may be used as an effective and safe modality for treatment in patients with major depressive disorder.
View study on PubMed →Systematic review · Adults with type 2 diabetes · 8 weeks
Curcumin shows potential benefits across multiple chronic conditions, largely driven by anti-inflammatory and antioxidant properties.
View on Healthline →Curcumin is one of the most studied plant compounds for reducing inflammation, with human evidence supporting its role in joint health, metabolic function, and inflammatory pathways. Its broad biological activity makes it a key ingredient in a longevity-focused formulation.
← Back to Daily DiversityFurther reading on Healthline →